JUNIPER PHARMACEUTICALS INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2015-05: Study NCT02465320; Company role Lead sponsor; Phase Phase 2; Status Completed.
- 2010-07: Study NCT01206998; Company role Collaborator; Phase Not applicable; Status Withdrawn.
- 2008-03: Study NCT00615550; Company role Lead sponsor; Phase Phase 3; Status Completed.
- 2007-08: Study NCT00651313; Company role Lead sponsor; Phase Phase 2; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2015-05 | NCT02465320 COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy | Lead sponsor | Phase 2 | Completed | Endometrial Biopsy | 187 | 2016-07 |
| 2010-07 | NCT01206998 Vaginal Progesterone as a Treatment for Women Active Preterm Labor | Collaborator Lead: University of Rochester | Not applicable | Withdrawn | Labor, Premature | 0 | 2010-08 |
| 2008-03 | NCT00615550 PREGNANT Short Cervix Trial | Lead sponsor | Phase 3 | Completed Results posted | Preterm Delivery; Short Cervix; Short Uterine Cervical Length | 465 | 2010-11 |
| 2007-08 | NCT00651313 Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods) | Lead sponsor | Phase 2 | Completed Results posted | Dysmenorrhea | 81 | 2008-08 |
| 2006-06 | NCT00343265 Vaginal Progesterone Versus Placebo in Multiple Pregnancy | Collaborator Lead: University of Calgary | Not applicable | Completed | Preterm Birth | 84 | 2011-03 |
| 2004-04 | NCT00086177 Vaginal Progesterone to Reduce the Risk of Another Preterm Birth | Lead sponsor | Phase 3 | Completed | Pregnancy | 636 | 2009-03 |